Cargando…
Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy with heterogeneous clinical presentation and genetic background. The axonal form (CMT2) is characterised by decreased action potentials indicating primary axonal damage. The underlying pathology involves axonal degeneration wh...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539360/ https://www.ncbi.nlm.nih.gov/pubmed/26032230 http://dx.doi.org/10.1007/s00415-015-7778-4 |
_version_ | 1782386096142811136 |
---|---|
author | Bansagi, Boglarka Antoniadi, Thalia Burton-Jones, Sarah Murphy, Sinead M. McHugh, John Alexander, Michael Wells, Richard Davies, Joanna Hilton-Jones, David Lochmüller, Hanns Chinnery, Patrick Horvath, Rita |
author_facet | Bansagi, Boglarka Antoniadi, Thalia Burton-Jones, Sarah Murphy, Sinead M. McHugh, John Alexander, Michael Wells, Richard Davies, Joanna Hilton-Jones, David Lochmüller, Hanns Chinnery, Patrick Horvath, Rita |
author_sort | Bansagi, Boglarka |
collection | PubMed |
description | Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy with heterogeneous clinical presentation and genetic background. The axonal form (CMT2) is characterised by decreased action potentials indicating primary axonal damage. The underlying pathology involves axonal degeneration which is supposed to be related to axonal protein dysfunction caused by various gene mutations. The overlapping clinical manifestation of CMT2 with distal hereditary motor neuropathy (dHMN) and intermediate CMT causes further diagnostic difficulties. Aminoacyl-tRNA synthetases have been implicated in the pathomechanism of CMT2. They have an essential role in protein translation by attaching amino acids to their cognate tRNAs. To date six families have been reported worldwide with dominant missense alanyl-tRNA synthetase (AARS) mutations leading to clinically heterogeneous axonal neuropathies. The pathomechanism of some variants could be explained by impaired amino acylation activity while other variants implicating an editing defect need to be further investigated. Here, we report a cohort of six additional families originating from the United Kingdom and Ireland with dominant AARS-related neuropathies. The phenotypic manifestation was distal lower limb predominant sensorimotor neuropathy but upper limb impairment with split hand deformity occasionally associated. Nerve conduction studies revealed significant demyelination accompanying the axonal lesion in motor and sensory nerves. Five families have the c.986G>A, p.(Arg329His) variant, further supporting that this is a recurrent loss of function variant. The sixth family, of Irish origin, had a novel missense variant, c.2063A>G, p.(Glu688Gly). We discuss our findings and the associated phenotypic heterogeneity in these families, which expands the clinical spectrum of AARS-related neuropathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-015-7778-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4539360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-45393602015-08-19 Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland Bansagi, Boglarka Antoniadi, Thalia Burton-Jones, Sarah Murphy, Sinead M. McHugh, John Alexander, Michael Wells, Richard Davies, Joanna Hilton-Jones, David Lochmüller, Hanns Chinnery, Patrick Horvath, Rita J Neurol Original Communication Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy with heterogeneous clinical presentation and genetic background. The axonal form (CMT2) is characterised by decreased action potentials indicating primary axonal damage. The underlying pathology involves axonal degeneration which is supposed to be related to axonal protein dysfunction caused by various gene mutations. The overlapping clinical manifestation of CMT2 with distal hereditary motor neuropathy (dHMN) and intermediate CMT causes further diagnostic difficulties. Aminoacyl-tRNA synthetases have been implicated in the pathomechanism of CMT2. They have an essential role in protein translation by attaching amino acids to their cognate tRNAs. To date six families have been reported worldwide with dominant missense alanyl-tRNA synthetase (AARS) mutations leading to clinically heterogeneous axonal neuropathies. The pathomechanism of some variants could be explained by impaired amino acylation activity while other variants implicating an editing defect need to be further investigated. Here, we report a cohort of six additional families originating from the United Kingdom and Ireland with dominant AARS-related neuropathies. The phenotypic manifestation was distal lower limb predominant sensorimotor neuropathy but upper limb impairment with split hand deformity occasionally associated. Nerve conduction studies revealed significant demyelination accompanying the axonal lesion in motor and sensory nerves. Five families have the c.986G>A, p.(Arg329His) variant, further supporting that this is a recurrent loss of function variant. The sixth family, of Irish origin, had a novel missense variant, c.2063A>G, p.(Glu688Gly). We discuss our findings and the associated phenotypic heterogeneity in these families, which expands the clinical spectrum of AARS-related neuropathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-015-7778-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-06-02 2015 /pmc/articles/PMC4539360/ /pubmed/26032230 http://dx.doi.org/10.1007/s00415-015-7778-4 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Communication Bansagi, Boglarka Antoniadi, Thalia Burton-Jones, Sarah Murphy, Sinead M. McHugh, John Alexander, Michael Wells, Richard Davies, Joanna Hilton-Jones, David Lochmüller, Hanns Chinnery, Patrick Horvath, Rita Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland |
title | Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland |
title_full | Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland |
title_fullStr | Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland |
title_full_unstemmed | Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland |
title_short | Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland |
title_sort | genotype/phenotype correlations in aars-related neuropathy in a cohort of patients from the united kingdom and ireland |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539360/ https://www.ncbi.nlm.nih.gov/pubmed/26032230 http://dx.doi.org/10.1007/s00415-015-7778-4 |
work_keys_str_mv | AT bansagiboglarka genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT antoniadithalia genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT burtonjonessarah genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT murphysineadm genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT mchughjohn genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT alexandermichael genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT wellsrichard genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT daviesjoanna genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT hiltonjonesdavid genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT lochmullerhanns genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT chinnerypatrick genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland AT horvathrita genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland |